CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


TetrandrineWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D014777 Virus Diseases NIH 0.12

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Clinical Study of Tetrandrine Tablets Adjuvant Treatment With COVID-19

The study is expected to treat patients with mild and severe neo-coronary pneumonia through standard treatment regimens in combination with tetrandrine tablets, thereby reducing the clinical progress of some patients, improving prognosis, reducing the incidence of pulmonary fibrosis during rehabilitation, and improving patients' quality of life.

NCT04308317 Corona Virus Disease 2019,COVID-19 Drug: Tetrandrine
MeSH:Virus Diseases

Primary Outcomes

Description: Death event

Measure: Survival rate

Time: 12 weeks

Secondary Outcomes

Description: inflammatory indicator

Measure: body temperature

Time: 2 weeks


No related HPO nodes (Using clinical trials)